グルコースバイオセンサーの世界市場の規模及び予測:エンドユーザー別(病院、ホームケア診断、研究機関、診断センター、診療所)、地域別(米国、英国、ドイツ、中国、インド、ブラジル、サウジアラビア、南アフリカ)、動向分析、2015-2022

【英語タイトル】Glucose Biosensor Market Size & Forecast By End-use (Hospitals, Homecare Diagnostics, Research Institutes, Diagnostic Centers, Clinics), By Region (U.S., UK, Germany, China, India, Brazil, Saudi Arabia, South Africa) And Trend Analysis From 2015 To 2022

Grand View Researchが出版した調査資料(GVIEW707367)・商品コード:GVIEW707367
・発行会社(調査会社):Grand View Research
・発行日:2016年2月22日
・ページ数:89
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,700 ⇒換算¥531,100見積依頼/購入/質問フォーム
Multi UserUSD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
Global/corporate LicenseUSD10,500 ⇒換算¥1,186,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、グルコースバイオセンサーの世界市場について調査・分析し、グルコースバイオセンサーの世界市場動向、グルコースバイオセンサーの世界市場規模、市場予測、セグメント別グルコースバイオセンサー市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

Global Glucose Biosensor Market is expected to reach USD 31.0 billion by 2022, according to a new report by Grand View Research Inc. The global Glucose Biosensor Market is anticipated to witness lucrative growth during the period of 2015 to 2022.
Some key factors attributing to the growth of this market include the increasing incidence of diabetes across the globe, development of technologically advanced products, growing demand for minimally and non-invasive products, patient awareness levels, and the need for early diabetes detection. However, presence of other alternatives for management of the diabetes, such as laboratory methods is expected to restrict market growth.

The glucose biosensors industry by end-use is segmented on the basis of its use in hospitals, homecare diagnostics, and others including research institutes, diagnostics, and clinical laboratories. The homecare diagnostics Glucose Biosensor Market is projected to flourish over the forecast period. Ease-of-use, quick results, and low costs of the tests are some aspects supporting market growth. On the other hand, the hospital-based Glucose Biosensor Market is projected to grow at a significant CAGR of 10.3% during the period 2015 to 2022.

Further key findings from the study suggest:

North America led the market, in terms of value, with a share of about 37% in 2015. High disease burden and the subsequent need to curb associated healthcare expenditure in the U.S., has resulted in this country account for a large revenue share of the North American market in 2014. According to the Centers of Disease Control (CDC), around 22.3 million people in the U.S. were estimated to be diagnosed with diabetes in the year 2013.
Asia Pacific is anticipated to witness lucrative growth during the forecast period. This market is projected to grow rapidly during the period 2015 to 2022. China and India are expected to spearhead market growth in this region.
The homecare diagnostics Glucose Biosensor Market was the largest in 2014. The segment is anticipated to grow at a rapid CAGR during the forecast period. As of 2015, the market was led by North America owing to the region’s highest disease burden and homecare diagnostics adoption rates.
The Glucose Biosensor Market comprises several local as well as global players. Some major players of this industry include Roche, Bayer and LifeScan, Inc..

【レポートの目次】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Glucose biosensors Market – Industry Summary and Key Buying Criteria, 2012 – 2020
Chapter 3. Glucose biosensors Industry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2012-2020
3.3. Glucose biosensors: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Rising prevalence of diabetes
3.3.1.2. Presence of a strong range of products in pipeline
3.3.1.3. Growing prevalence of lifestyle induced disorders such as obesity
3.3.2. Market restraint analysis
3.3.2.1. Presence of alternative methods
3.4. Glucose biosensors market: Industry trend analysis
3.5. Glucose biosensors Market – PESTEL Analysis
3.6. Glucose biosensors Industry analysis – Porter’s Five Forces Model
3.7. Glucose biosensors: Company Market Share Analysis (%), 2014
3.8. Key opportunities prioritized
Chapter 4. Glucose Biosensors End-User Application Outlook
4.1. Glucose Biosensors Revenue Share (%) Analysis, by End-User Application, 2014 & 2022
4.2. Hospital
4.2.1. Hospital market revenue, by region, 2012 to 2022 (USD Million)
4.3. Homecare Diagnostics
4.3.1. Homecare diagnostics market revenue, by region, 2012 to 2022 (USD Million)
4.4. Others
4.4.1. Others market revenue, by region, 2012 to 2022 (USD Million)
Chapter 5. Glucose Biosensors Regional Outlook
5.1. Glucose Biosensors Market Share (%) Analysis, by Region, 2014 & 2022
5.2. North America
5.2.1. U.S.
5.2.1.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.2.2. Canada
5.2.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.3. Europe
5.3.1. Germany
5.3.1.1. glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.3.2. U.K.
5.3.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.3.3. Rest of Europe
5.3.3.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.4. Asia Pacific
5.4.1. China
5.4.1.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.4.2. India
5.4.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.4.3. Rest of Asia Pacific
5.4.3.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.5. MEA
5.5.1. South Africa
5.5.1.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.5.2. Saudi Arabia
5.5.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.5.3. Rest of MEA
5.5.3.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.6.2. Mexico
5.6.2.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
5.6.3. Rest of Latin America
5.6.3.1. Glucose biosensors market, by end-user application, 2012 – 2022 (USD Million)
Chapter 6. Competitive Landscape
6.1. Roche Diagnostics
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. LifeScan Inc.
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Abbott Laboratories
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. Bayer
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. Medtronic Inc.
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Pinnacle Medical Solutions Inc.
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. AgaMatrix Inc.
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. Sanofi S.A.
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. BioSense Medical Devices, LLC
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives
6.10. Nova Biomedical
6.10.1. Company Overview
6.10.2. Financial Performance
6.10.3. Product Benchmarking
6.10.4. Strategic Initiatives



★調査レポート[グルコースバイオセンサーの世界市場の規模及び予測:エンドユーザー別(病院、ホームケア診断、研究機関、診断センター、診療所)、地域別(米国、英国、ドイツ、中国、インド、ブラジル、サウジアラビア、南アフリカ)、動向分析、2015-2022] (コード:GVIEW707367)販売に関する免責事項を必ずご確認ください。
★調査レポート[グルコースバイオセンサーの世界市場の規模及び予測:エンドユーザー別(病院、ホームケア診断、研究機関、診断センター、診療所)、地域別(米国、英国、ドイツ、中国、インド、ブラジル、サウジアラビア、南アフリカ)、動向分析、2015-2022]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆